INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBITOR FOR HAE
INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBITOR FOR HAE
批准号:
7606584
负责人:
Bruce L. Zuraw
金额:
$1.01万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
确定与安慰剂相比,C1 INH-nf治疗受试者至定义症状缓解的中位时间是否更短。 检验接受C1 INH-nr治疗的受试者与接受安慰剂治疗的受试者相比,至缓解的时间是否不同。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Determine whether C1INH-nf treated subjects have shorter median time to relief of the defining symptoms compared to placebo. Test whether time to relief is different in subjects treated with C1INH-nr compared to placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10412915
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10516092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10044412
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:7929357
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:8196318
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:8391112
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:8166834
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2009
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:7950979
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBI
-
批准号:7724937
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHARMACOKINETICS OF C1INH-NF IN HEREDITARY ANGIOEDEMA SUBJECTS
-
批准号:7724962
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:7724969
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8330064
-
项目类别:
-
资助金额:$36.83万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8711195
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8897958
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma
-
批准号:7150800
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8516971
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8381195
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:6922726
-
项目类别:
-
资助金额:$41.98万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:7086290
-
项目类别:
-
资助金额:$47.14万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:7224163
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位: